Steady-state activation of the high-affinity isoform of the α4β2δ GABAA receptor
Authors:
Open Access
- 5 November 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Abstract
Activation of GABAA receptors consisting of α4, β2 (or β3), and δ subunits is a major contributor to tonic inhibition in several brain regions. The goal of this study was to analyze the function of the α4β2δ receptor in the presence of GABA and other endogenous and clinical activators and modulators under steady-state conditions. We show that the receptor has a high constitutive open probability (~0.1), but is only weakly activated by GABA that has a maximal peak open probability (POpen,peak) of 0.4, taurine (maximal POpen,peak = 0.4), or the endogenous steroid allopregnanolone (maximal POpen,peak = 0.2). The intravenous anesthetic propofol is a full agonist (maximal POpen,peak = 0.99). Analysis of currents using a cyclic three-state Resting-Active-Desensitized model indicates that the maximal steady-state open probability of the α4β2δ receptor is ~0.45. Steady-state open probability in the presence of combinations of GABA, taurine, propofol, allopregnanolone and/or the inhibitory steroid pregnenolone sulfate closely matched predicted open probability calculated assuming energetic additivity. The results suggest that the receptor is active in the presence of physiological concentrations of GABA and taurine, but, surprisingly, that receptor activity is only weakly potentiated by propofol.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (GM108580)
This publication has 42 references indexed in Scilit:
- Steady-State Activation and Modulation of the Concatemeric α1β2γ2L GABAA ReceptorMolecular Pharmacology, 2019
- Applying the Monod-Wyman-Changeux Allosteric Activation Model to Pseudo–Steady-State Responses from GABAA ReceptorsMolecular Pharmacology, 2019
- High and low GABA sensitivity α4β2δ GABAA receptors are expressed in Xenopus laevis oocytes with divergent stoichiometriesBiochemical Pharmacology, 2016
- Mutations in the GABAA Receptor that Mimic the Allosteric Ligand Etomidate2011
- Distinct activities of GABA agonists at synaptic‐ and extrasynaptic‐type GABAAreceptorsThe Journal of Physiology, 2010
- Modulation of Spontaneous and GABA-Evoked Tonic α4β3δ and α4β3γ2L GABAAReceptor Currents by Protein Kinase AJournal of Neurophysiology, 2010
- Novel compounds selectively enhance δ subunit containing GABAA receptors and increase tonic currents in thalamusNeuropharmacology, 2009
- Activation‐Dependent Properties of Pregnenolone Sulfate Inhibition of GABAA Receptor‐Mediated CurrentThe Journal of Physiology, 2003
- Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptorsBritish Journal of Pharmacology, 2002
- Pregnenolone sulfate block of GABAA receptors: mechanism and involvement of a residue in the M2 region of the α subunitThe Journal of Physiology, 2001